Accomplishments
Complete antibody development at UBC; Prototype development; Patent new discoveries
SCREENING & EARLY DETECTION
Survival rates are higher for patients whose cancer is detected early.
NEWS & EVENTS
BioMark’s CTA application to Health Canada for Phase III Trial June 2012 is approved.